North America In Vitro Diagnostics Quality Control Market Size & Outlook

The in vitro diagnostics quality control market in North America is expected to reach a projected revenue of US$ 738.3 million by 2030. A compound annual growth rate of 2.9% is expected of North America in vitro diagnostics quality control market from 2024 to 2030.
Revenue, 2023 (US$M)
$602.9
Forecast, 2030 (US$M)
$738.3
CAGR, 2024 - 2030
2.9%
Report Coverage
North America

North America in vitro diagnostics quality control market, 2018-2030 (US$M)

North

Related Markets

North America in vitro diagnostics quality control market highlights

  • The North America in vitro diagnostics quality control market generated a revenue of USD 602.9 million in 2023.
  • The market is expected to grow at a CAGR of 2.9% from 2024 to 2030.
  • In terms of segment, controls was the largest revenue generating product in 2023.
  • Calibrators is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, U.S. is expected to register the highest CAGR from 2024 to 2030.


North America data book summary

Market revenue in 2023USD 602.9 million
Market revenue in 2030USD 738.3 million
Growth rate2.9% (CAGR from 2023 to 2030)
Largest segmentControls
Fastest growing segmentCalibrators
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationControls, Calibrators
Key market players worldwideSiemens Healthineers AG ADR, Abbott Laboratories, Bio-Rad Laboratories Inc, Danaher Corp, Roche Holding AG ADR, Sysmex Corp, QuidelOrtho Corp, Thermo Fisher Scientific Inc, BD, Merck KGaA, Qiagen NV, Hologic Inc, Bio-Techne Corp, Randox, Helena Laboratories, Seracare Life Sciences, Fortress Diagnostics, Microbiologics, TRINA BIOREACTIVES, Cone Bioproducts, Biorex Food Diagnostics


Other key industry trends

  • In terms of revenue, North America region accounted for 47.1% of the global in vitro diagnostics quality control market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 320.5 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

In Vitro Diagnostics Quality Control Market Scope

In vitro diagnostics quality control market segmentation & scope
Total Protein
Albumin
Blood Urea Nitrogen
Uric Acid
Creatinine
Sodium
Potassium
Chloride
Calcium
Magnesium
Inorganic Phosphorus
Aspartate Transaminase
Creatine Kinase
Gamma Glutamyl transferase
Total Bilirubin
Glucose
Iron
Alanine Transaminase
Alkaline Phosphatase
Alpha Amylase
Total Cholesterol
Triglyceride
Lactate Dehydrogenase
Immunoglobulin G
Immunoglobulin A
Immunoglobulin M
Complement 3
Complement 4
C-Reactive Protein
Rheumatoid Factor
Anti-Streptolysin -O
Beta 2 Micorgloblin
Cystatin-C
Myoglobin
Troponin T and I
Others
Calibrators
Others
Plasma-based Control
Serum-based Control
Whole blood-based Control
Others
Quality Assurance Services
Data Management Solutions
Immunochemistry
Hematology
Alkaline Phosphatase (ALP)
Alanine Transaminase (ALT)
Aspartate Transaminase (AST)
Creatine Kinase MB (CK-MB)
Albumin
Creatinine
Glucose
Triglycerides
Amylase
Others
Molecular Diagnostics
Coagulation
Microbiology
Others
Independent Controls
Instrument Specific Controls
OEM Controls
Hospitals
Laboratories
Home Care
Others

In Vitro Diagnostics Quality Control Market Companies

Name Profile # Employees HQ Website

North America in vitro diagnostics quality control market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro diagnostics quality control market will help companies and investors design strategic landscapes.


Controls was the largest segment with a revenue share of 48.33% in 2023. Horizon Databook has segmented the North America in vitro diagnostics quality control market based on controls, calibrators covering the revenue growth of each sub-segment from 2018 to 2030.


North America is one of the developed regions with high healthcare expenditure and held a substantial share of the global in vitro diagnostics quality control market in 2023. This large share can be attributed to the presence of a well-established healthcare system and clinical diagnostics industry in the U.S.

which has created a significant demand for internal & external quality control solutions for clinical and research purposes. In addition, continuous advancements in the field of IVD and high affordability & adoption of innovative and advanced diagnostic systems & solutions in the region make it an attractive market globally. 

The presence of the U.S. FDA and many accredited diagnostic laboratories, coupled with strong quality control regulation systems, is driving market expansion in the region. According to the American Clinical Laboratory Association.

Reasons to subscribe to North America in vitro diagnostics quality control market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of North America in vitro diagnostics quality control market databook

  • Our clientele includes a mix of in vitro diagnostics quality control market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America in vitro diagnostics quality control market , including forecasts for subscribers. This continent databook contains high-level insights into North America in vitro diagnostics quality control market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

North America in vitro diagnostics quality control market size, by country, 2018-2030 (US$M)

North America In Vitro Diagnostics Quality Control Market Outlook Share, 2023 & 2030 (US$M)

North America in vitro diagnostics quality control market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more